immunotherapy
9 stories related to this topic, newest first.
The TimesNHS Rolls Out One-Minute Injection for Key Cancer Drug, Cutting Treatment Time
The UK's National Health Service is introducing an injectable form of the immunotherapy drug pembrolizumab, reducing administration time from up to two hours via intravenous drip to under a minute. This change affects treatment for 14 types of cancer and could benefit about 14,00…
Wikimedia Commons (Public domain)Study Finds Relacorilant May Extend Survival in Platinum-Resistant Ovarian Cancer Patients
A clinical trial showed that adding relacorilant to standard treatment extended median survival by 4.1 months for patients with platinum-resistant ovarian cancer. The study involved 381 participants and reported a 35 percent reduction in mortality risk. Separately, another trial…
Substrate placeholder — needs review · Wikimedia Commons (CC BY-SA 3.0)Challenges in Targeting Cancer Tumors with Immunotherapies and Viral Proteins
Immunotherapies and viral proteins that induce cell death serve as tools in cancer treatment. These methods face difficulties in selectively targeting tumors without affecting healthy cells. Researchers continue to explore ways to improve precision in such therapies.
Substrate placeholder — needs review · Wikimedia Commons (CC BY-SA 3.0)Researchers Report CAR-T Cell Therapy Success in Severe Autoimmune Disease Case
A 47-year-old woman with three severe autoimmune diseases received experimental CAR-T cell therapy in early 2025 after nine failed treatments. The therapy, originally developed for cancer, targets problematic immune cells to induce remission. The patient has since returned to nor…
Substrate placeholder — needs review · Wikimedia Commons (CC BY-SA 3.0)Nature Publishes Three New Research Papers on Plant Immunity, Genetic Disease Risks, and Cancer Immunotherapy
Nature journal released three research papers on October 10, 2024, addressing advancements in rice disease resistance, genetic repeat expansions linked to brain atrophy, and synthetic enhancers for viral immunotherapy. The studies highlight genetic mechanisms for crop protection,…
BruceBlaus / Wikimedia (CC BY-SA 4.0)Nature Publishes Three Research Papers on Genetics, Immunotherapy, and Social Science Reproducibility
Nature has released three new research papers addressing distinct scientific areas. One study analyzes population-scale repeat expansions to link them with disease risk and brain atrophy. Another develops synthetic super-enhancers for targeted viral immunotherapy, while a third e…
Nature Publishes Four New Research Papers on Superconductivity, Immunotherapy, Reproducibility, and Brain Activity
Nature journal released four research papers covering advancements in materials science, medical treatments, scientific methodology, and neuroscience. The papers address superconductivity in nickelate thin films, synthetic super-enhancers for viral immunotherapy, reproducibility…
Substrate placeholder — needs review · Wikimedia Commons (CC BY-SA 3.0)Nature Publishes Four New Research Papers on Superconductivity, Immunotherapy, Reproducibility, and Brain Activity
Nature journal released four research papers covering advancements in materials science, medical treatments, scientific methodology, and neuroscience. The papers address superconductivity in nickelate thin films, synthetic super-enhancers for viral immunotherapy, reproducibility…
National Institutes of Health. / Wikimedia (Public domain)Nature Publishes Four New Research Papers on Diverse Scientific Topics
Nature journal released four research papers covering advancements in viral immunotherapy, reproducibility in social sciences, neural activity dissociation, and chemical catalysis for olefins production. Each paper presents findings from specialized studies in biology, economics,…